Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDr. Martens Regulatory News (DOCS)

Share Price Information for Dr. Martens (DOCS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 78.70
Bid: 78.45
Ask: 79.40
Change: 1.85 (2.41%)
Spread: 0.95 (1.211%)
Open: 77.00
High: 79.35
Low: 76.00
Prev. Close: 76.85
DOCS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Chief Brand Officer Appointment

16 Nov 2023 07:00

RNS Number : 6029T
Dr. Martens PLC
16 November 2023
 

16 November 2023

Dr. Martens plc

Creation of Chief Brand Officer role

Ije Nwokorie appointed into new role and will step down as Non-Executive Director as a result

 

Dr. Martens plc announces that Non-Executive Director Ije Nwokorie will join as Chief Brand Officer from 1st February 2024. On appointment into this role, Ije will cease to be a member of the Board and will step down as a member of the Audit and Risk, Nomination and Disclosure committees.

The newly-created role of Chief Brand Officer will be a key member of the global leadership team, reporting into Kenny Wilson, CEO, overseeing the Global Marketing, Product and Strategy functions. The Chief Brand Officer will be responsible for setting the overall brand strategy, vision and direction for the next phase of Dr. Martens' growth.

Ije will join Dr. Martens as Chief Brand Officer from Apple Inc, where he has been Senior Director, Apple Retail since January 2018. Prior to this he spent 11 years at global brand consultancy Wolff Olins, where he was latterly CEO, leading teams in offices in San Francisco, London, Dubai and New York. He is currently also Chair of non-profit organisation charity: water UK.

Paul Mason, Chair, said "Ije has been a tremendous Non-Executive Director since he joined the Board in January 2021. He has deep insight and understanding of brands and has extensive global DTC experience. I am delighted that he'll be joining the leadership team as Chief Brand Officer, a role for which he is perfectly suited."

Kenny Wilson, CEO, said "Ije is a visionary brand storyteller and this, along with his infectious passion for Dr. Martens, makes him the ideal person to lead the next era of our brand development. I am delighted that he will be joining my team in a permanent full-time position of Chief Brand Officer, which will be a crucial role to enable us to become a £2bn revenue brand."

Ije Nwokorie said "I've always loved Dr. Martens and it's been a real privilege getting to know the brand from the inside as a Non-Executive Director. Dr. Martens is defined by its rebellious, authentic and creative nature, all of which makes me really excited to be joining Kenny and the team early in the new year and to get to work."

 

Enquiries

Investors and analysts

Bethany Barnes, Director of Investor Relations Bethany.Barnes@drmartens.com +44 7825 187465

Beth Callum, Senior Investor Relations Analyst Beth.Callum@drmartens.com +44 203 995 2644

 

Press

H/Advisors Maitland +44 207 379 5151

Clinton Manning +44 7711 972662

 

Gill Hammond, Director of Communications +44 7384 214248

 

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Produced originally for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens has since transcended its working-class roots while still celebrating its proud heritage and, six decades later, "Docs" or "DM's" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company is a constituent of the FTSE 250 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNBLBDBGUBDGXU
Date   Source Headline
1st May 20244:14 pmRNSTotal Voting Rights
16th Apr 20247:00 amRNSCEO succession
16th Apr 20247:00 amRNSFY24 trading and FY25 outlook update
12th Apr 20243:13 pmRNSDirector/PDMR Shareholding
28th Mar 20245:56 pmRNSTotal Voting Rights
12th Mar 20243:50 pmRNSDirector/PDMR Shareholding
1st Mar 202411:19 amRNSTotal Voting Rights
27th Feb 20247:00 amRNSCFO appointment update
14th Feb 20244:10 pmRNSDirector/PDMR Shareholding
5th Feb 20242:13 pmRNSDirector/PDMR Shareholding
1st Feb 202410:40 amRNSTotal Voting Rights
25th Jan 20247:00 amRNSQ3 FY24 Trading Statement
12th Jan 20241:58 pmRNSDirector/PDMR Shareholding
2nd Jan 202410:13 amRNSTotal Voting Rights
15th Dec 20236:20 pmRNSTransaction in Own Shares
14th Dec 20236:15 pmRNSTransaction in Own Shares
13th Dec 20236:02 pmRNSTransaction in Own Shares
12th Dec 20236:24 pmRNSTransaction in Own Shares
12th Dec 20231:42 pmRNSDirector/PDMR Shareholding
11th Dec 20236:04 pmRNSTransaction in Own Shares
8th Dec 20236:16 pmRNSTransaction in Own Shares
7th Dec 20236:23 pmRNSTransaction in Own Shares
6th Dec 20236:08 pmRNSTransaction in Own Shares
5th Dec 20236:20 pmRNSTransaction in Own Shares
4th Dec 20236:29 pmRNSTransaction in Own Shares
1st Dec 20236:20 pmRNSTransaction in Own Shares
1st Dec 20232:08 pmRNSHolding(s) in Company
1st Dec 20238:00 amRNSBlock listing Interim Review
30th Nov 20234:08 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSHalf-year Report
20th Nov 20236:07 pmRNSTransaction in Own Shares
17th Nov 20236:21 pmRNSTransaction in Own Shares
16th Nov 20236:23 pmRNSTransaction in Own Shares
16th Nov 20237:00 amRNSChief Brand Officer Appointment
15th Nov 20236:13 pmRNSTransaction in Own Shares
14th Nov 20235:58 pmRNSTransaction in Own Shares
14th Nov 202312:41 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSCFO Appointment
13th Nov 20236:06 pmRNSTransaction in Own Shares
10th Nov 20236:24 pmRNSTransaction in Own Shares
9th Nov 20236:03 pmRNSTransaction in Own Shares
8th Nov 20235:56 pmRNSTransaction in Own Shares
7th Nov 20236:23 pmRNSTransaction in Own Shares
6th Nov 20236:23 pmRNSTransaction in Own Shares
3rd Nov 20236:03 pmRNSTransaction in Own Shares
2nd Nov 20236:15 pmRNSTransaction in Own Shares
2nd Nov 20237:00 amRNSBlock listing application
1st Nov 20236:02 pmRNSTransaction in Own Shares
1st Nov 20233:47 pmRNSTotal Voting Rights
24th Oct 20235:38 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.